ArticleCancer innovation2026

Treatment Outcomes With Novel Targeted and Immunotherapeutic Regimens in CAYA Hodgkin Lymphoma: A Retrospective Study.

Mengqing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.